Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70 - Full Text View

Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70

This study has been completed.

Sponsored by:	Alcon Research
Information provided by:	Alcon Research
ClinicalTrials.gov Identifier:	NCT00047541

Purpose

To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.

Condition	Intervention	Phase
Open-Angle Glaucoma Ocular Hypertension	Drug: Alcon Investigational Agent	Phase III

Genetics Home Reference related topics:

early-onset glaucoma

MedlinePlus related topics:

Glaucoma High Blood Pressure

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study

Official Title:	Phase III Safety and Efficacy Study to Evaluate Combination IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertensive Patients C-01-70.

Further study details as provided by Alcon Research:

Study Start Date:	February 2001
Study Completion Date:	November 2003
Primary Completion Date:	November 2003 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension; visual acuity of 20/80 to 20/400 or better (Snellen equivalent) or logMAR visual acuity not worse than 0.6. Clinically relevant ophthalmic or systemic conditions may be excluded.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00047541

Locations


United States, Texas
	Clinical Trial Sites
	Fort Worth, Texas, United States, 76134

Sponsors and Collaborators

Alcon Research

More Information

Study ID Numbers:	C-01-70, C-01-70
First Received:	October 8, 2002
Last Updated:	August 4, 2008
ClinicalTrials.gov Identifier:	NCT00047541
Health Authority:	United States: Food and Drug Administration

Keywords provided by Alcon Research:

open-angle

glaucoma

ocular

hypertension

POAG

Study placed in the following topic categories:

Glaucoma

Eye Diseases

Glaucoma, Open-Angle

Vascular Diseases

Hypertension

Ocular Hypertension

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on August 21, 2008